Survival in Norwegian BRCA1 mutation carriers with breast cancer. - Wikidata - wikimedia - TriplyDB

Survival in Norwegian BRCA1 mutation carriers with breast cancer.

Survival in Norwegian BRCA1 mutation carriers with breast cancer.

http://www.wikidata.org/entity/Q37182133

about

Worse breast cancer prognosis of BRCA1/BRCA2 mutation carriers: what's the evidence? A systematic review with meta-analysis.Our genes, our selves: hereditary breast cancer and biological citizenship in Norway.Breast cancer after bilateral risk-reducing mastectomy.

P2860

Q35224593-F1B1F2A4-06C6-49E1-8CCE-958459648E85 Q38814369-16C3D968-A0B4-4C6B-BD5D-F51908BAA6EA Q39797410-58225B53-8106-48A2-89A1-6F993A4C4C9A

P2860

Survival in Norwegian BRCA1 mutation carriers with breast cancer.

http://www.wikidata.org/entity/Q37182133

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 14 April 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Survival in Norwegian BRCA1 mutation carriers with breast cancer.

@en

Survival in Norwegian BRCA1 mutation carriers with breast cancer.

@nl

type

label

Survival in Norwegian BRCA1 mutation carriers with breast cancer.

@en

Survival in Norwegian BRCA1 mutation carriers with breast cancer.

@nl

prefLabel

Survival in Norwegian BRCA1 mutation carriers with breast cancer.

@en

Survival in Norwegian BRCA1 mutation carriers with breast cancer.

@nl

P1433

Q37182133-6A5FD5F7-1131-4860-AA82-B14D4B57CCFD

P1476

Q37182133-8ACC1635-8700-4913-845E-08A88C82FD92

P2093

Q37182133-19A630A1-B89E-40A2-B058-DEE5F0E1577F

Q37182133-37A7B954-2FC8-4CD7-9C33-008DD5D8720C

Q37182133-56550284-7AD0-4FC8-A60A-01A44CB96AC8

Q37182133-6FC09DA4-F59F-4C36-977E-01EEC7BED925

Q37182133-C102A890-111F-4B62-9568-D1F292D428BB

Q37182133-C37726B2-8F03-4E24-AC47-D55BEF48CA4D

P2860

Q37182133-028F4356-0D48-4C92-9ED1-D9D1281CF86E

Q37182133-02DB5F04-4B47-45D2-B57F-B98A586D317C

Q37182133-08987841-4DF3-4932-A74A-ED45C40AC019

Q37182133-0F279624-3CA2-4A6E-AF5B-1348FD598312

Q37182133-15C2E7DC-44F9-44F2-9B78-87FF82447F71

Q37182133-4026DB5A-D074-4DB8-8747-BDA22C7381EA

Q37182133-40F60FFC-19ED-4227-B2C2-18BBE367FEAC

Q37182133-6D5DF946-3DE4-4888-9970-5161D56D696F

Q37182133-745317AA-2A8E-4212-9CF8-84A4C4087AF2

Q37182133-7631E622-C585-4D46-9CE0-8254BBEEDD52

P2888

Q37182133-9F94ECAE-AA8A-4BD0-8BCD-0FEB77E9150B

P304

Q37182133-A0C09A8B-7D98-4C73-8FD2-D438D76505FE

P31

Q37182133-16E7048B-4764-4A44-A105-1CA221952D34

P356

Q37182133-E4F97498-4083-49B0-9D6E-DECA7627BD63

P433

Q37182133-D1DA6508-A3F3-4C6A-9903-9FDDD80F6B82

P478

Q37182133-4A4A2AD0-99CB-4D09-9945-CBEEE1FB04A8

P577

Q37182133-A819D13B-688A-4B57-BEAC-024FC9F3B604

P5875

Q37182133-C7901DD9-6693-44E4-8104-7888E939E2D0

P6179

Q37182133-20002E18-54D1-4CAE-9EB8-49B00E009B13

P698

Q37182133-2E5FA3B7-0A0C-4044-834C-7F0834771063

P932

Q37182133-03DCE03F-5297-427F-A5FC-8C7B88B1DEB3

P356

P1433

Hereditary Cancer in Clinical Practice

P1476

Survival in Norwegian BRCA1 mutation carriers with breast cancer.

@en

P2093

Anne Irene Hagen

http://www.w3.org/2001/XMLSchema#string

Jaran Apold

http://www.w3.org/2001/XMLSchema#string

Lovise Maehle

http://www.w3.org/2001/XMLSchema#string

Nina Vedå

http://www.w3.org/2001/XMLSchema#string

Pål Møller

http://www.w3.org/2001/XMLSchema#string

Steinar Tretli

http://www.w3.org/2001/XMLSchema#string

P2860

Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

Impact of germline BRCA1 mutations and overexpression of p53 on prognosis and response to treatment following breast carcinoma: 10-year follow up data.

Survival and prognostic factors in BRCA1-associated breast cancer.

Germline BRCA1/2 mutations and p27(Kip1) protein levels independently predict outcome after breast cancer.

Predictive molecular markers in the adjuvant therapy of breast cancer: state of the art in the year 2002.

The p63/p73 network mediates chemosensitivity to cisplatin in a biologically defined subset of primary breast cancers

Prognosis of early-onset breast cancer based on BRCA1/2 mutation status in a French population-based cohort and review.

BRCA1 expression modulates chemosensitivity of BRCA1-defective HCC1937 human breast cancer cells

Survival of breast cancer patients in BRCA1, BRCA2, and non-BRCA1/2 breast cancer families: a relative survival analysis from Finland.

P2888

P304

7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1897-4287-7-7

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2009-04-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24277596

http://www.w3.org/2001/XMLSchema#string

P6179

1028742251

http://www.w3.org/2001/XMLSchema#string

P698

19366445

http://www.w3.org/2001/XMLSchema#string

P932

2678098

http://www.w3.org/2001/XMLSchema#string